We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

151 hedge funds and large institutions have $299M invested in Definium Therapeutics in 2024 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $3.77M

63% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 27

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

12% more funds holding

Funds holding: 135 → 151 (+16)

9% less capital invested

Capital invested by funds: $327M → $299M (-$28.2M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

26.45% less ownership

Funds ownership: 84.24% → 57.79% (-26%)

Holders
151
Holders Change
+16
Holders Change %
+11.85%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
44
Increased
39
Reduced
24
Closed
27
Calls
$14.4M
Puts
$3.77M
Net Calls
+$10.6M
Net Calls Change
-$11.6M

Top Buyers

1
BlackRock
BlackRock
New York
+$40.1M
2
State Street
State Street
Massachusetts
+$14.7M
3
CC
Commodore Capital
New York
+$11.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.84M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$18.8M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$8.11M
3
SCM
Soleus Capital Management
Connecticut
-$7.05M
4
DTC
Deep Track Capital
Connecticut
-$4.92M
5
Millennium Management
Millennium Management
New York
-$3.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
151
Millennium Management
New York
– -$3.65M -388,202 Closed
TCM
152
Tang Capital Management
California
– -$2.82M -300,000 Closed
Susquehanna International Group
153
Susquehanna International Group
Pennsylvania
– -$2.36M -269,596 Closed
HF
154
HRT Financial
New York
– -$1.95M -207,253 Closed
D.E. Shaw & Co
155
D.E. Shaw & Co
New York
– -$1.72M -183,029 Closed
TI
156
Tidal Investments
Wisconsin
– -$1.7M -180,600 Closed
Qube Research & Technologies (QRT)
157
Qube Research & Technologies (QRT)
United Kingdom
– -$1.09M -116,327 Closed
Squarepoint
158
Squarepoint
New York
– -$504K -57,650 Closed
LCM
159
Laurion Capital Management
New York
– -$286K -30,426 Closed
VF
160
Virtu Financial
New York
– -$239K -25,440 Closed
YIH
161
Y-Intercept (HK)
Hong Kong
– -$219K -23,316 Closed
LP
162
LMR Partners
United Kingdom
– -$154K -16,374 Closed
CIM
163
Chiron Investment Management
New York
– -$150K -15,932 Closed
PCMH
164
Polymer Capital Management (HK)
Hong Kong
– -$112K -11,926 Closed
BHCM
165
Brevan Howard Capital Management
Jersey
– -$100K -10,649 Closed
Macquarie Group
166
Macquarie Group
Australia
– -$36 -3,779 Closed
SAG
167
SageView Advisory Group
California
– -$238K -2,648 Closed
SPM
168
Symmetry Peak Management
Pennsylvania
– -$7K -800 Closed
Federated Hermes
169
Federated Hermes
Pennsylvania
– -$2.32K -247 Closed
FG
170
Fairman Group
Pennsylvania
– -$799 -85 Closed
Toronto Dominion Bank
171
Toronto Dominion Bank
Ontario, Canada
– -$517 -55 Closed
VL
172
Vima LLC
Michigan
– -$92 -29 Closed
PP
173
Pacifica Partners
Canada
– -$208 -20 Closed
SPIA
174
Steward Partners Investment Advisory
New York
– -$56 -6 Closed
FGAM
175
Financial Gravity Asset Management
Texas
– -$19 -2 Closed
4 5 6
7
8

DFTX Hedge Fund Activity: Q2 2024 in Review

151 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2024, worth a combined $299M — down 8.6% from $327M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new DFTX positions and 27 closed out — a net gain of 17 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $40.1M. The largest seller was Great Point Partners, exiting entirely with an estimated $18.8M sold.

  • 151 institutional investors held Definium Therapeutics (DFTX) as of Q2 2024, up from 135 in Q1 2024.
  • Funds reported $299M of Definium Therapeutics stock for Q2 2024, down 8.6% quarter-over-quarter.
  • 44 funds opened new Definium Therapeutics positions in Q2 2024 and 27 closed out, a net change of +17 holders.
  • The largest Definium Therapeutics buyer in Q2 2024 was BlackRock, an estimated $40.1M added.
  • The largest Definium Therapeutics seller in Q2 2024 was Great Point Partners, an estimated $18.8M sold.

Based on aggregated 13F filings for Q2 2024.